The brown cluster, also representing a niche theme, associates pediatric MASLD with chemerin’s dual inflammatory and anti-inflammatory functions, though it is notably showing elevated levels in NAFL patients, but no significant differences between NASH patients and controls [54]. Here, RARRES2 is linked to non-alcoholic fatty liver.